Skip to main content

Table 4 Epidemiological information on all patients

From: Effects of rhBMP-2 with various carriers on maxillofacial bone regeneration through computed tomography evaluation

 

Group 1 (n = 53)

Group 2 (n = 59)

Age (years)

46.47 ± 15.49

38.29 ± 18.03

Gender

 Male

28

24

 Female

25

35

Diagnosis

 Cyst

7

21

 Benign tumor

36

36

 Osteomyelitis

6

0

 Inflammation

4

2

 Defect size (cc)

3.930 ± 2.282

3.345 ± 2.241

 Compromised wall

1.25

1.28